DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
JAMA 2002;
288: 2981-2997
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.